Selected novel 5'-amino-2'-hydroxy-1,3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G0/G1 phase by Simon, Lalitha et al.
EXCLI Journal 2016;15:21-32 – ISSN 1611-2156 
Received: October 01, 2015, accepted: December 22, 2015, published: January 13, 2016 
 
 
21 
Original article: 
SELECTED NOVEL 5’-AMINO-2’-HYDROXY-1, 3-DIARYL-2-
PROPEN-1-ONES ARREST CELL CYCLE OF HCT-116  
IN G0/G1 PHASE 
 
Lalitha Simon1, K. K. Srinivasan2, Nitesh Kumar3, Neetinkumar D. Reddy3,  
Subhankar Biswas3, C. Mallikarjuna Rao3*, Sudheer Moorkoth4 
 
1 Department of Chemistry, Manipal Institute of Technology, Manipal University, Manipal, 
576 104, India 
2 Department of Chemistry, Shri Madhwa Vadiraja Institute of Technology & Management, 
(affiliated to Visvesvaraya Technological University, Belgaum), Bantakal, Udupi, 574115, 
India 
3 Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal  
University, 576 104, India 
4 Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical  
Sciences, Manipal University, 576 104, India 
 
* Corresponding author: Dr. C. Mallikarjuna Rao, Principal & Professor of Pharmacology, 
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, 576 104,  
Karnataka, India, Tel: +91 8202922482,  
E-mail: mallikin123@gmail.com, mallik.rao@manipal.edu 
 
 
http://dx.doi.org/10.17179/excli2015-610 
 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/). 
 
ABSTRACT 
A series of 5’-amino-2’-hydroxy-1,3-diaryl-2-propen-1-ones (AC1-AC15) were synthesized by Claisen-Schmidt 
condensation of 5'-acetamido-2’-hydroxy acetophenone with various substituted aromatic aldehydes. The syn-
thesized compounds were characterized by FTIR, 1H NMR and mass spectrometry and evaluated for their selec-
tive cytotoxicity using MTT assay on two cancer cell lines namely breast cancer cell line (MCF-7), colon cancer 
cell line (HCT-116) and one normal kidney epithelial cell line (Vero). Among the tested compounds, AC-10 
showed maximum cytotoxic effect on MCF-7 cell line with IC50 value 74.7 ± 3.5 µM. On HCT-116 cells, AC-13 
exhibited maximum cytotoxicity with IC50 value 42.1 ± 4.0 µM followed by AC-14 and AC-10 with IC50 values 
62 ± 2.3 µM and 95.4 ± 1.7 µM respectively. All tested compounds were found to be safe on Vero cell line with 
IC50 value more than 200 µM. Based on their highest efficacy on HCT-116, AC-10, AC-13 and AC-14 were 
selected for mechanistic study on this cell line by evaluating changes nucleomorphological characteristics using 
acridine orange-ethidium bromide (AOEB) dual stain and by analyzing cell cycle with flow cytometry using 
propidium iodide stain. In AOEB staining, all three tested compounds showed significant (p < 0.05) increase in 
percentage apoptotic nuclei compared to control cells, with highest increase in apoptotic nuclei by AC-13 treat-
ment (31 %). Flow cytometric studies showed cell cycle arrest by AC-10 and AC-14 treatment in G0/G1 phase 
and by AC-13 in G0/G1 and G2/M phase. The study reflected the potential of AC-10, AC-13 and AC-14 to be the 
lead molecules for further optimization. 
Keywords: 5’-amino-2’-hydroxy-1,3-diaryl-2-propen-1-ones, cytotoxicity, MTT, acridine orange-ethidium 
bromide nuclear staining, flow cytometry  
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INTRODUCTION 
Cancer is rapid and uncontrolled growth 
of abnormal cells. It is the major cause of 
death, after cardiovascular diseases all over 
the world (Bandgar et al., 2010). Most of the 
drugs available today for the treatment of 
cancer are cytotoxic in nature, which act by 
interfering with the operation of the cell's 
DNA in some way. These cytotoxic drugs 
are very harmful to the body unless the drugs 
are specific to target cancer cells. The cancer 
specific targeting by cytotoxic agents is dif-
ficult to achieve because the modifications, 
which convert healthy cell into cancerous 
one are very subtle. Thus a major challenge 
is always present in designing new drugs 
with more selectivity for cancer cells. 
1,3-Diaryl-2-propen-1-ones, commonly 
known as chalcones, belong to the flavonoid 
family (Bennett et al., 1980; Chiaradia et al., 
2008; Chimenti et al., 2009). Structurally, 
they contain an open-chain flavonoid skele-
ton in which two aromatic rings are linked 
by a three-carbon α,β-unsaturated carbonyl 
system. Chalcones exhibit a wide range of 
biological activities, which include anti-
cancer (Chen et al., 1994; Dimmock et al., 
1999), anti-inflammatory (Chiaradia et al., 
2008; Domı́nguez et al., 2001; Fu et al., 
2004), antioxidant (Go et al., 2005), antimi-
crobial, anti-tubercular (Gold and Moeller-
ing, 1996; Kawabata et al., 2003), antimalar-
ial (Lust et al., 2005) and anti-allergic activi-
ties (Kouskoura et al., 2008).The biological 
activities of chalcones are considered to be 
due to the presence of a reactive α,β-
unsaturated keto function, while the presence 
of a double bond allows these molecules to 
exist as cis or trans geometric isomers. The 
trans-isomer has been proven to be thermo-
dynamically as well as biologically favoura-
ble. 
Many naturally occurring chalcones with 
potent anticancer efficacy against a variety 
of cancer cell lines have been found. Lico-
chalcone A, an oxygenated chalcone found 
in the roots of the Chinese liquorice (Glycyr-
rhiza uralensis), has been demonstrated to 
possess many bioactive properties including 
anti-parasitic, estrogenic, antimalarial and 
antitumor activities (Khatib et al., 2005; Mi-
randa et al., 2000; Modzelewska et al., 
2006). Xanthohumol, a prenylated chalcone 
isolated from the hop cones (Humuluslupu-
lus L.) is suggested to exhibit broad spec-
trum anticancer properties against different 
types of human cancer cells primarily 
through inhibition of proliferation and induc-
tion of human cancer cell apoptosis 
(Mosmann, 1983; Nowakowska, 2007). Fla-
vokawain A, B, and C (Go et al., 2005; Gold 
and Moellering, 1996; Kawabata et al., 
2003) in kava extracts have been shown to 
possess strong antiproliferative and apoptotic 
effect in human bladder cancer cells (Palkar 
and Master, 2000). 
Introduction of amino groups into vari-
ous heterocyclic systems had led to very ef-
fective therapeutic agents. 5-Amino flavones 
showed antitumor activity highly selective to 
the ER-positive breast cancer cell line (Pan 
et al., 2005). 6-Aminoflavone inhibited 
mammalian intestinal α-glucosidase (Srini-
vasan et al., 2009). 5,4’-Diamino-6,8,3’-tri-
fluoroflavone (Wu et al., 2011) exhibited 
strong growth inhibitory activity against 
MCF-7 cells. But very little has been report-
ed on the synthesis and biological activities 
of chalcones with a free amino substitution 
in the ring A. Studies on the anticancer po-
tential of chalcones having amino group in 
the 5th position, and hydroxyl group at the 
2nd positions of ring A of chalcones have not 
been reported as of our knowledge. In view 
of the wide spectrum of medicinal applica-
tions of chalcone derivatives, our research 
continues to explore the anticancer potential 
of flavonoids having free amino group/s. The 
present study includes the synthesis, charac-
terization and mechanistic insight into anti-
cancer activities of some new 5’-amino-2’-
hydroxy-1,3-diaryl-2-propen-1-ones.  
 
MATERIALS AND METHODS 
Experimental 
The chemicals required for the synthesis 
were purchased from Sigma Aldrich, Hi-
Media, Loba Chemicals and Nice Fine 
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Chemical India. Melting points were record-
ed by open capillary method and purity was 
assessed using Rf value in thin layer chroma-
tography (TLC) on pre-coated silica gel alu-
minium backed plates (Kieselgel 60 F254 
Merck (Germany)). The IR spectra in KBr 
pellets were recorded using Shimadzu FTIR 
8400S spectrophotometer. 1H NMR spectra 
were recorded by Bruker AV400 (400MHz) 
spectrometer in deuterated dimethyl sulphox-
ide using tetramethyl silane as internal 
standard. Mass spectra were scanned on a 
Shimadzu LCMS (ESI) 2010A spectrometer. 
5’-Acetamido-2’-hydroxy acetophenone (2) 
(Figure 1) was prepared according to the 
known procedure. 5’-acetamido-2’-hydroxy-
1,3-diaryl-2-propen-1-ones (3) (Figure 1) 
were prepared by procedure given in the lit-
erature (Wu et al., 2003). 
General procedure for the synthesis of 5’-
amino-2’-hydroxy -1,3-diaryl-2-propen-1-
ones (AC1 –AC15) 
A mixture of concentrated hydrochloric 
acid and water (1:1) was added to 5’-
acetamido-2’-hydroxy chalcone, and boiled 
for one hour. The reaction progress was 
monitored with TLC using petroleum ether-
ethyl acetate solvent system in the ratio 2:3. 
When the reaction was complete, the reac-
tion mixture was cooled to room temperature 
and ice cold water was added. The solution 
was basified by adding 10 % sodium bicar-
bonate solution. The product obtained was 
filtered and purified by recrystallization from 
ethanol to get amino chalcones (Figure 1). 
 
 
Figure 1: Scheme for the synthesis of 5’-amino-2’-hydroxy-1,3-diaryl-2-propen-1-ones 
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Characterization 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-
phenylprop-2-en-1-one (AC-1): Light Brown 
solid, yield: 72 %; m.p. 126 °C; IR (KBr) 
νmax/cm−1: 3425, 3340 (NH2), 3565 (OH), 
1690 (α,β-unsaturated C=O), 3026 (Ar-CH), 
1136 (C-N ), 1510 (C=C); 1H NMR (400 
MHz, DMSO-d6): δ ppm 5.43 (s,2H,NH2), 
6.60 (d, 1H,J = 2.5 Hz), 6.71 (d, 1H, J = 15.7 
Hz), 6.90 (d, 1H, J = 2.5 Hz), 7.47 (m, 3H), 
7.51 ( d, 1H, J = 15.7 Hz), 7.71 (dd,1H, J = 
2.5 Hz, 8.9 Hz), 7.79 (m, 2H), 8.17 (d, 1H, J 
= 2.5 Hz), 11.70 (s, OH); LCMS (m/z): 239 
(M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
chlorophenyl)prop-2-en-1-one (AC-2): Dark 
Brown solid, yield: 70 %; m.p. 138 °C; 
IR(KBr) νmax/cm−1 : 3450, 3341 (NH2), 3588 
(OH), 1683 (α,β-unsaturated C=O), 3070 
(Ar-CH), 1130 (C-N), 1510 (C=C); 1H NMR 
(400MHz, DMSO-d6): δppm 5.34 (s, 2H, 
NH2), 6.97 (d, 1H, J = 8.9 Hz), 7.24 (t, 2H,J 
= 8.9 Hz), 7.63 (dd, 1H, J = 2.5, 8.9 Hz), 
7.70 (d, 1H,J = 15.7 Hz), 7.78 (d, 1H, J = 
15.7 Hz), 7.84 (d, 2H, J = 8.9 Hz), 8.18 (d, 
1H, J = 2.5 Hz), 11.81 (s, 1H,OH); LCMS 
(m/z): 273 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
fluorophenyl)prop-2-en-1-one (AC-3): Pale 
brown solid, yield: 68 %; m.p. 154 °C; 
IR(KBr) νmax/cm−1: 3430, 3329 (NH2), 3572 
(OH), 1690 (α,β-unsaturated C=O), 3062 (Ar 
-CH), 1130 (C-N), 1510 (C=C); 1H NMR 
(400MHz, DMSO-d6): δppm; 5.48 (s, 2H, 
NH2), 6.97 (d, 1H, J = 8.9 Hz), 7.32 (d, 2H,J 
= 8.9 Hz), 7.71 (dd, 1H, J = 2.5, 8.9 Hz), 
7.73 (d, 1H,J = 15.7 Hz), 7.78 (d, 1H, J = 
15.7 Hz), 7.90 (t, 2H, J = 8.9 Hz), 8.18 (d, 
1H, J = 2.5 Hz), 11.73 (s, 1H,OH); LCMS 
(m/z): 257 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(3-
nitrophenyl)prop-2-en-1-one (AC-4): Brown 
solid, yield: 50 %; m.p. 112 °C; IR (KBr) 
νmax/cm−1: 3420, 3319 (NH2), 3570 (OH), 
1676 (α,β-unsaturated C=O) 3060 (Ar-CH), 
1130 (C-N), 1510 (C=C); 1H NMR (400 
MHz, DMSO-d6): δppm: 5.40 (s, 2H, NH2), 
6.97 (d, 1H, J = 8.9 Hz), 7.46 (d, 2H,J = 8.9 
Hz), 7.88 (dd, 1H, J = 2.5, 8.9 Hz), 7.93 (d, 
1H,J = 16.2 Hz), 8.01 (d, 1H, J = 16.2 Hz), 
8.26 (t, 2H, J = 8.9 Hz), 8.30 (d, 1H, J = 2.5 
Hz), 11.86 (s,1H,OH); LCMS (m/z): 284 
(M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
ethoxyphenyl)prop-2-en-1-one (AC-5): 
Brown solid, yield: 68 %; m.p. 135 °C; 
IR(KBr) νmax/cm−1: 3420, 3329 (NH2), 3568 
(OH), 1692 (α,β-unsaturated C=O), 3060 
(Ar-CH), 1130 (C-N), 1510 (C=C); 1HNMR 
(400 MHz, DMSO-d6): δppm: 1.40 
(t,3H,CH3), 4.23 (q,2H,OCH2), 5.43 
(s,2H,NH2), 6.75 (d,1H,J=8.4Hz), 6.86 
(d,1H,J=16Hz), 6.98 (d,1H,J=8.0Hz), 7.06 
(d,2H,J=8.0Hz), 7.46 (d,2H,J=8.0Hz), 7.771 
(d,1H,J=16Hz), 7.84 (d,1H,J=8.8Hz), 11.8 
(s,1H,OH); LCMS (m/z): 283 (M+).   
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(3-
methoxyphenyl)prop-2-en-1-one (AC-6): 
Brown solid, yield: 79 %; m.p. 110 °C; IR 
(KBr) νmax/cm−1: 3415, 3329 (NH2), 3588 
(OH), 1672 (α,β-unsaturated C=O), 3060 (Ar 
-CH), 1130(C-), 1510(C=C); 1H NMR (400 
MHz, DMSO-d6): δppm: 3.81 (s, OCH3), 
5.43 (s,2H,NH2), 6.96 (d, 1H, J = 8.9 Hz), 
7.04 (m,1H), 7.37 (m, 3H), 7.71 (dd, 1H, J = 
8.9, 2.5 Hz), 7.72 (d, 1H, J = 15.7 Hz), 7.79 
(d, 1H, J = 15.7 Hz), 8.14(d, 1H, J = 2.5 Hz, 
11.71 (s, OH); LCMS (m/z): 269 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
hydroxy-3-methoxyphenyl)prop-2-en-1-one 
(AC-7): Brown solid, yield: 61 %; m.p. 
136 °C; IR (KBr) νmax/cm−1: 3446, 3301 
(NH2), 3591 (OH), 1680 (α,β-unsaturated 
C=O), 3078 (Ar-CH), 1138 (C-N), 1520 
(C=C); 1H NMR (400 MHz, DMSO-d6): 
δppm: 3.89 (s,3H,OCH3), 5.37 (s,2H,NH2), 
7.84 (d,1H,J=8.8Hz), 7.77 (s,1H), 7.46 
(d,2H,J=8.0Hz), 7.06 (d,2H,J=8.0Hz), 6.98 
(d,1H,J=8.0Hz), 6.86 (d,1H,J=16Hz), 6.75 
(d,1H,J=8.4Hz), 11.8 (s,1H,OH); LCMS 
(m/z): 285 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(3-
hydroxy-4-methoxyphenyl)prop-2-en-1-one 
(AC-8): Pale brown solid, yield: 61 %; m.p. 
136 °C; IR (KBr) νmax/cm−1: 3446, 3301 
(NH2), 3589 (OH), 1680 (α,β-unsaturated 
C=O), 3078 (Ar-CH), 1138 (C-N), 1520 
(C=C); 1H NMR (400 MHz, DMSO-d6): 
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δppm: 3.81 (s,3H,OCH3), 5.40 (s,2H,NH2), 
7.84 (d,1H,J=8.8Hz), 7.77 (s,1H), 7.46 
(d,2H,J=8.0Hz), 7.06 (d,2H,J=8.0Hz), 6.98 
(d,1H,J=8.0Hz), 6.86 (d,1H,J=16Hz), 6.75 
(d,1H,J=8.4Hz), 11.5 (s,1H,OH); LCMS 
(m/z): 285 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-
(3,4-dimethoxyphenyl)prop-2-en-1-one (AC-
9): Brown solid, yield: 73 %; m.p. 90 °C; 
IR(KBr) νmax/cm−1: 3430, 3329 (NH2), 3588 
(OH), 1690 (α,β-unsaturated C=O), 3062 
(Ar-CH), 1130 (C-N), 1510 (C=C); 1H NMR 
(400 MHz, DMSO-d6): δppm: 3.78 (6H,s, 23 
x OCH3), 5.48 (s, 2H, NH2), 6.97 (d, 1H, J = 
8.9 Hz), 7.32 (d, 2H, J = 8.9 Hz), 7.71 (d, 
1H, J = 2.5, 8.9 Hz), 7.73 (d, 1H,J = 15.7 
Hz), 7.78 (d, 1H, J = 15.7 Hz), 7.90 (s, 1H), 
8.18 (d, 1H, J = 2.5 Hz), 11.73 (s, 1H,OH); 
LCMS (m/z): 299 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(2-
hydroxyphenyl)prop-2-en-1-one (AC-10): 
Dark brown solid, yield: 68 %; m.p. 130-
132 °C; IR(KBr) νmax/cm−1: 3448, 3320 
(NH2), 3576 (OH), 1692 (α,β-unsaturated 
C=O), 3062 (Ar -CH), 1138 (C-N), 1510 
(C=C); 1H NMR (400MHz, DMSO-d6): 
δppm.; 5.39 (s, 2H, NH2), 6.97 (d, 1H, J = 
8.9 Hz), 7.32 d, 2H,J = 8.9 Hz), 7.64 (d, 1H, 
J = 2.5, 8.9 Hz), 7.75 (d, 1H,J = 15.7 Hz), 
7.78 (d, 1H, J = 15.7 Hz), 7.90 (s, 1H), 8.18 
(d, 1H, J = 2.5 Hz), 11.80 (s, 1H,OH); 
LCMS (m/z): 255 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
methoxyphenyl)prop-2-en-1-one (AC-11): 
Brown solid, yield: 72 %; m.p. 102-104 °C; 
IR (KBr) νmax/cm−1: 3450, 3344 (NH2), 
3591(OH), 1678 (α,β-unsaturated C=O), 
3070 (Ar-CH), 1138 (C-N), 1515 (C=C); 1H 
NMR (400 MHz, DMSO-d6): δppm: 3.84 
(s,3H, OCH3), 5.43 (s,2H,NH2), 7.84 
(d,1H,J=8.8Hz), 7.771 (d,1H,J=16Hz), 7.46 
(d,2H,J=8.0Hz), 7.06 (d,2H,J=8.0Hz), 6.98 
(d,1H,J=8.0Hz), 6.86 (d,1H,J=16Hz), 6.75 
(d,1H,J=8.4Hz), 11.8 (s,1H,OH); LCMS 
(m/z): 269(M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-
(3,4-dichlorophenyl)prop-2-en-1-one (AC-
12): Brown solid, yield: 70 %; m.p. 138 °C; 
IR(KBr) νmax/cm−1: 3450, 3341 (NH2), 3580 
(OH), 1690 (α,β-unsaturated C=O), 3070 
(Ar-CH), 1130 (C-N), 1510 (C=C); 1H NMR 
(400MHz, DMSO-d6): δppm: 5.34 (s, 2H, 
NH2), 7.01 (d, 1H, J = 8.9 Hz), 7.24 (d, 2H,J 
= 8.9 Hz), 7.63 (d, 1H, J = 2.5, 8.9 Hz), 7.70 
(d, 1H,J = 15.7 Hz), 7.78 (d, 1H, J = 15.7 
Hz), 7.86 (s,1H Hz), 8.18 (d, 1H, J = 2.5 
Hz), 11.75 (s, 1H,OH); LCMS (m/z): 308 
(M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-
(3,4-methylenedioxyphenyl)prop-2-en-1-one 
(AC-13): Pale brown solid, yield: 81 %; m.p. 
128 °C; IR (KBr) νmax/cm−1: 3446, 3301 
(NH2), 3591 (OH), 1680 (α,β-unsaturated 
C=O), 3078 (Ar-CH), 1138 (C-N), 1520 
(C=C); 1H NMR (400 MHz, DMSO-d6): 
δppm: 5.40 (s,2H,NH2), 6.034 (s,2H,CH2-O), 
6.90 (d,1H,J=8.4Hz), 6.96 (d,1H,J=16Hz), 
6.99 (d,1H,J=8.0Hz), 7.06 (d,2H,J=8.0Hz), 
7.46 (d,2H,J=8.0Hz), 7.70 (s,1H), 7.84 
(d,1H,J=8.8 Hz), 11.5 (s,1H,OH); LCMS 
(m/z): 283 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-
(3,4,5-trimethoxyphenyl)prop-2-en-1-
one(AC-14): Light Brown solid, yield: 81 %; 
m.p. 136-138 °C; IR (KBr) νmax/cm−1: 3430, 
3329 (NH2), 3588 (OH), 1690 (α,β-
unsaturated C=O), 3062 (Ar-CH), 1130 (C-
N), 1510 (C=C); 1H NMR (400 MHz, 
DMSO-d6): δppm: 3.85 (9H,s, 3 x OCH3), 
5.48 (s, 2H, NH2), 7.50 (d, 1H, J = 8.9 Hz), 
7.32 (d, 1H,J = 8.9 Hz), 7.71 (d, 1H, J = 2.5, 
8.9 Hz), 7.73 (d, 1H,J = 15.7 Hz), 7.78 (d, 
1H, J = 15.7 Hz), 7.93 (s, 2H), 11.73 
(s,1H,OH); LCMS (m/z): 329 (M+). 
(E)-1-(5-Amino-2-Hydroxyphenyl)-3-(4-
benzyloxyphenyl)prop-2-en-1-one (AC-15): 
Dark Brown solid, yield: 73 %; m.p. 136-
138 °C; IR (KBr) νmax/cm−1: 3425, 3340 
(NH2), 3565 (OH), 1690 (α,β-unsaturated 
C=O), 3026 (Ar-CH), 1136 (C-N), 1510 
(C=C); 1H NMR (400 MHz, DMSO-d6): 
δppm: 5.25 (s, 2H, Ar-CH2-), 5.50 
(s,2H,NH2), 7.11 (dd, 1H, J =2.5Hz, 8.9 Hz), 
7.29 (d, 1H,J=17Hz), 7.47 (dd, 2H, J =2.5Hz, 
8.9 Hz), 7.71 (d, 2H, J = 2.5 Hz), 7.77 (d, 
2H, J = 2.5 Hz), 7.79 (d,2H, J = 2.5 Hz), 7.82 
(d,1H, J = 2.5 Hz), 7.87 (d,1H,J=17Hz), 8.01 
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(d,1H, J = 2.5 Hz), 8.17 (d, 1H, J = 2.5 Hz), 
11.70 (s, OH); LCMS (m/z): 345 (M+). 
 
Evaluation of cytotoxicity by MTT assay 
Cytotoxicity of the synthesized com-
pounds was evaluated in cancer cells namely 
human colon cancer (HCT-116) cells and 
human breast cancer (MCF-7) cells and 
normal kidney epithelial cells (Vero). These 
cells were originally procured from National 
Cancer Center for Cell Science, Pune, India 
and cultured in our lab using Dulbecco’s 
modified Eagles medium (DMEM) contain-
ing 10 % fetal bovine serum (FBS) at 37 °C 
in an atmosphere containing 5 % CO2. All 
other chemicals used in this study were pur-
chased from Sigma-Aldrich, USA. 
Cell suspension containing 1x104 cells in 
0.1 mL was seeded in a 96 well plate for 
24 h. Test compounds were serially diluted 
with the medium to get a stock solution of 
400 µM, 200 µM, 100 µM, 50 µM. After 
24 h of incubation, 100 µL of test solution 
from respective stocks was added in tripli-
cate and incubated for 48 h. After the treat-
ment, drug-containing media was removed 
and 20 µL of MTT reagent (5 mg/mL in 
PBS) was added to each well. After 4 h of 
incubation at 37 °C, the MTT reagent was 
removed and 100 µL of 100 % DMSO was 
added to each well to solubilize formazan 
crystals. The optical density was measured 
using an ELISA plate reader at 540 nm and 
percentage cytotoxicity was calculated. 
(Kumar et al., 2012; Zi and Simoneau, 
2005). 
 
Acridine orange (AO) and Ethidium  
bromide double staining using fluorescent 
microscopy 
DNA-binding dyes Acridine orange 
(AO) and Ethidium bromide (EB) (Sigma, 
USA) were used for the morphological de-
tection of apoptotic cells. 5 x 103 cells were 
seeded per well in 24-well plates with 
DMEM, containing 10 % FBS. After 24 h, 
cells were treated with selected concentra-
tions of test compounds and incubated for 
24 h. The media was removed and plate was 
washed with phosphate buffer saline (PBS, 
pH 7.4). Cells were fixed in ice-cold metha-
nol for 20 min, washed with PBS again and 
stained with acridine orange and ethidium 
bromide stain (20/30 µg/ml). After incuba-
tion for 20 min at 37 °C, and washing with 
PBS thrice, the plate was observed under a 
fluorescent microscope for morphological 
changes in nucleus such as condensed chro-
matin and fragmented nuclei. The apoptotic 
index (AI) was calculated as % of apoptotic 
cells from randomly counted 100 cells in 
each treatment group (Reddy et al., 2015). 
 
Cell cycle analysis 
Flow cytometric analysis technique eval-
uates the effect of test compounds on cell 
cycle progression and check-points. Cells (1 
x 106) were seeded in 25 cm2 flasks and, af-
ter overnight adherence, incubated with test 
compounds. Then cells were detached by 
trypsinization and mixed with floating cells, 
centrifuged and washed with PBS. The cell 
pellets were fixed in 70 % ice-cold methanol 
and stored at -20 °C for 24 h. After that cell 
pellets were washed with PBS and isotonic 
PI solution [25 µM propidium iodide, 0.03 % 
NP-40 and 40 µg /ml RNase A] was added. 
The stained cells were analyzed using Accuri 
C6 flow cytometer (BD Biosciences, San 
Jose, CA, USA) with excitation at 488 nm 
and emission at 575/40 nm (Reddy et al., 
2015). 
 
Statistical analysis 
Statistical analysis of data were per-
formed by one way ANOVA followed by 
Tukey’s post hoc using Graph Pad Prism v 
5.03 (demo version), CA, USA, where 
p<0.05 was considered to be significant. 
 
RESULTS 
Chemistry 
A series of chalcones having amino sub-
stituent at the 5th position and hydroxyl sub-
stituent at the 2nd position of ring A and dif-
ferent substituents in the 2nd, 3rd, 4th, 5th posi-
tions of ring B were synthesized. The acet-
amido chalcones were synthesized by 
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Claisen–Schmidt condensation of substituted 
benzaldehydes and 5’-acetamido-2’-hydroxy 
acetophenone. All the compounds were ob-
tained in excellent yields (70-90 %). The ac-
etamido chalcones were hydrolysed in acidic 
medium to obtain amino chalcones in good 
yields (50-81 %) (Figure 2). 
OH
R'
H2N
O
1'
2'
3'
4'
5'
6'
1
3
4
5
2
6
 
Figure 2: Structure of 5’-amino-2’-hydroxy chal-
cone 
 
 
In vitro cytotoxicity by MTT assay method 
Fifteen 5’-amino-2’-hydroxy chalcones 
were evaluated for their cytotoxicity against 
two human tumor cell lines. Among the 
compounds analyzed, seven (viz., AC-2, 
AC-3, AC-8, AC-9, AC-10, AC-13 and AC-
14) displayed high cytotoxicity (close to 
200 µM including SEM) against HCT-116 
and five compounds (AC-8, AC-9, AC-10, 
AC-13, AC-14) against MCF-7 cells. Most 
of the compounds were free from cytotoxici-
ty to normal kidney epithelial cells (Vero) at 
< 200 µM concentration, which indicated the 
selectivity of the compounds towards tested 
tumor cells. The results are presented in Ta-
ble 1.  
 
Table 1: Cytotoxicity of 5’-amino-2’-hydroxy 
chalcones by MTT assay after 48 h incubation 
Compound 
Code 
IC50 (µM) 
 HCT-116 MCF-7 Vero 
AC-1 
AC-2 
AC-3 
AC-4 
AC-5 
AC-6 
AC-7 
AC-8 
AC-9 
AC-10 
AC-11 
AC-12 
AC-13 
AC-14 
AC-15 
299.2±49.79 
205.3±3.15 
174±3.53 
309.3±74.1 
No activity 
No activity 
392.7±77.9 
123.3±7.2 
185.7±7.3 
95.4±1.7 
No activity 
169.4±66.7 
42.1± 4.0 
62±2.3 
211.4±26 
1956±776 
No activity 
541.5±38.5 
No activity 
No activity 
No activity 
247.9±4.31 
170.6±12.9 
190.2±10.5 
74.7±3.5 
1033±60.6 
236.5±9.8 
130.3±3.8 
196.6±7.9 
No activity 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200 
>200
All values are mean ± SEM of three independent 
triplicates. IC50 were determined by nonlinear 
regression using Graph Pad Prism v 5.03 (demo 
version), CA, USA. 
 
 
AO/EB (dual) nuclear staining 
HCT-116 cells treated with compounds 
show changes in cellular morphology, in-
cluding chromatin condensation and frag-
mented nuclei, which are characteristic fea-
tures of an early apoptotic cell death (green 
colour) but not necrosis (orange colour) 
(Nayak et al., 2013; Reddy et al., 2015). AC-
10, AC-13 and AC-14 were tested at their 
IC50 value i.e, 100, 50 and 50 µM, respec-
tively. All tested compounds produced mor-
phological changes in the nuclei and showed 
significant (p < 0.05) increase in apoptotic 
nuclei. AC-13 showed maximum increase in 
percentage apoptotic nuclei (31 ± 4.16 %) 
followed by AC-10 (27 ± 3.21 %) and AC-
14 (24.3 ± 3.53 %) (Figures 3 and 4). 
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Figure 3: Nuclear staining. The representative images for induction of apoptosis by different treat-
ments for 48 h in HCT-116 cells by AO/EB. Apoptotic index was calculated by counting specific pat-
tern of condensed and fragmented nuclear morphology. 
 
 
Figure 4: Apoptotic index. All values are mean 
± SEM of three readings in triplicate. Data are 
analysed by one way ANOVA followed by Tuk-
ey’s post hoc test, where ap<0.05 compared to 
medium control 
 
 
Cell cycle analysis 
The effect of the compounds on cell cy-
cle phase was assessed and the results are 
shown as % cells in G0/G1, S, and G2/M 
phase. The normal control showed 62.3, 15.3 
and 23.0 % cells in G0/G1, S and G2/M 
phase, respectively. The standard, doxorubi-
cin (1 µM), accumulated 7.4 % cells in G2/M 
phase as compared with that of normal con-
trol suggesting cell cycle arrest at G2/M 
phase. The test compounds AC-10 (100 µM), 
AC-13 (50 µM), and AC-14 (50 µM), caused 
accumulation of cells (70.5 %, 66.5 % and 
70.8 %), in G0/G1, phase which indicated the 
arrest of cell cycle in this phase. In addition 
AC-13 also showed accumulation of cells in 
G2/M phase (25.1 %) (Figure 5). 
 
DISCUSSION 
Several reports are available which state 
that chalcone, both derived from nature and 
synthetic sources, exhibit cytotoxic and anti-
tumor activities (Ducki et al., 1998). Fla-
vokawain B, a chalcone of plant origin sig-
nificantly prevents colon cancer cells 
growth. It produces ROS generation and 
GADD153 up-regulation leading to mito-
chondria-dependent apoptosis through re-
lease of cytochrome C and the translocation 
of Bak (Kuo et al., 2010). 
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Figure 5: Effect on the cell cycle of HCT-116 after 48 h treatment with AC-10, AC-13 and AC-14. The 
concentrations used for cell cycle analysis were 100 µM for AC-10, 50 µM for AC-13 and AC-14. 
 
 
The structures of synthesized compounds 
were confirmed with FT-IR and 1H NMR 
and mass spectroscopy. The FT-IR spectra of 
the newly synthesized chalcones displayed a 
strong absorption band due to α,β-unsatur-
ated C=O stretching at 1692–1672 cm-1, 
3591-3565 cm-1 (Ar-OH), 3078-3026 cm-1 
(Ar–H), 3344-3319 cm-1 (NH2). Inspection 
of the 1H-NMR spectra suggested that the 
chalcones presented trans configurations (J 
= 15-17 Hz). The other expected peaks were 
in the region of 11.50-11.81 ppm (s, Ar-OH), 
5.34-5.50 ppm (s, Ar-NH2), 6.90-8.18 ppm 
(Ar-H). The OCH3 protons resonated at 
3.85 ppm and were observed as a singlet. 
The mass spectra of all newly synthesized 
amino chalcones showed molecular ion 
peaks, which were in accordance with their 
respective molecular masses. 
The results revealed that the most potent 
compounds were AC-13, AC-10 and AC-14. 
The 3,4-methylene substitution (AC-13), 2-
hydroxy substitution (AC-10), and 3,4,5-
trimethoxy substitution (AC-14) on ring B of 
the chalcone increase the cytotoxic activity. 
Regarding the structure activity relationship, 
it appeared that the number of methoxy 
groups in ring B is important for cytotoxici-
ty. AC-14 with three methoxy groups at 3,4 
and 5 positions of ring B showed good activ-
ity with IC50 62 ± 2.3 µM and 196.6 ± 
7.9 µM against HCT-116 and MCF-7 respec-
tively whereas compounds having one meth-
oxy group at 3 or 4 positions of ring B (AC-
6, AC-11) and two methoxy substituents at 3 
and 4 positions of ring B (AC-1) were inac-
tive. It is observed that AC-9 with no sub-
stituent on ring B was more active than com-
pounds having electron withdrawing groups 
like NO2, F or Cl at the 4 position of ring B. 
The compound AC-8 with OH substitution at 
3 and OMe substitution at 4 positions of ring 
B showed significant cytotoxicity. However, 
when the positions of OH and OMe were 
interchanged, as in AC-7, the cytotoxicity 
was reduced. 
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Nuclear staining method using fluores-
cent dye is an ideal method for detection of 
morphonuclear changes viz., nuclear con-
densation, fragmentation and a disrupted 
membrane with cytoplasmic disintegration 
(Reddy et al., 2015). AO/EB stain can easily 
permeate to the cell and stain the 
DNA/RNA. It is also helpful in identifying 
apoptotic changes in the cell. Compound 
with lowest IC50 values namely, AC-10, AC-
13 and AC-14, were selected for evaluation 
of apoptotic changes on the colon cancer 
cells (HCT-116) using acridine or-
ange/ethidium bromide double staining tech-
nique. Treatments showed increased apopto-
sis compared to untreated control cells. The 
nucleomorphological changes such as apop-
totic nuclei in the form of nuclear condensa-
tion and fragmentation were significantly 
(p<0.05) high in the treated cells compared 
to control cells. AC-13 treatment was found 
to be more effective with about five times 
increase in apoptotic nuclei compared to me-
dium control (Figures 3 and 4). 
Flow cytometry analysis is one of the 
important methods to identify the effect of 
cytotoxic drug on cell cycle analysis 
(Riccardi and Nicoletti, 2006). The healthy 
cells undergo mitotic phase and divide into 
two distinct daughter cells. The cells pass 
through different phases of cycle namely 
G0/G1, S and G2/M to ensure proper division 
of the cells. Any abnormality detected in the 
cell cycle leads to arrest further growth with 
the help of check-points. In the present 
study, the regulation of cell cycle check-
points in HCT cancer cells was studied by 
cell cycle analysis using propidium iodide 
staining. The effect of the compounds on cell 
cycle phase was assessed and the results of 
the same were shown as the percentage of 
cells in G0/G1, S, and G2/M phase. The 
standard, doxorubicin (1 µM), showed 7.4 % 
more accumulation of cells in G2/M phase as 
compared to normal control. This suggests 
that cell cycle arrest is at G2/M phase. The 
test compounds, AC-10 and AC-14, caused 
accumulation of cells in G0/G1 phase while 
AC-13 produced accumulation of cells in 
G0/G1 and G2/M phase. These accumulations 
of cells indicated the arrest of cell cycle by 
AC-10, and AC-14 in G0/G1 phase and by 
AC-13 in G0/G1 and G2/M phase. The results 
obtained were in accordance with the earlier 
reports on chalcones, which state that cell 
cycle arrest by chalcones happens in either 
G0/G1 phase or G2/M phase (Shen et al., 
2007). 
 
CONCLUSION 
In this study, a series of fifteen 5’-amino-
2’-hydroxy-1,3-diaryl-2-propen-1-ones were 
synthesized and characterized. The com-
pound AC-13 exhibited maximum cytotoxi-
city in HCT-116 and moderate cytotoxicity 
in MCF-7. AC-10 exhibited best cytotoxicity 
in MCF-7. The AO/EB staining showed the 
extent of apoptotic damage. AC-13 displayed 
highest % of apoptotic nuclei and arrested 
cell cycle in G0/G1 and G2/M phase and AC-
10 and AC-14 arrested G0/G1 phase of the 
cell cycle. 
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